CAV1 and neoplasm: To test whether CAV1 modulates the UPR during tumor growth, B16F10(Mock) and B16F10(CAV1) melanoma cells were injected subcutaneously into syngenic C57BL/6 mice to evaluate tumor progression in vivo.